Zymeworks Inc.
Pharmaceutical company · Middletown, Delaware, United States · Nasdaq: ZYME
Zymeworks Inc. is a pharmaceutical company headquartered in Middletown, Delaware, United States. Its earliest recorded incorporation is in 2022. Its shares trade on Nasdaq under the ticker ZYME. It has reported private securities offerings to the US SEC, most recently $50 million sold in a notice filed in 2024.
Zymeworks at a glance
What does Zymeworks do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $50 million sold (2024).
Frequently asked questions about Zymeworks
Where is Zymeworks headquartered?
Zymeworks Inc. is headquartered in Middletown, Delaware, United States.
What does Zymeworks do?
Zymeworks Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Zymeworks a public company?
Yes. Zymeworks Inc. trades on Nasdaq under the ticker ZYME.
When was Zymeworks founded?
The earliest incorporation on record for Zymeworks Inc. is in 2022, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences